Prognostic value of surfactant proteins A and D in patients with acute lung injury

Critical Care Medicine

Volumn 31, Issue 1, 2003, Pages 20-27

  Cheng, Ivan W ^a   Ware, Lorraine B ^b   Greene, Kelly E ^c   Nuckton, Thomas J ^a   Eisner, Mark D ^a   Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Pulmonary edema; Surfactant

Indexed keywords

BIOCHEMICAL MARKER; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; LUNG ALVEOLUS OXYGEN TENSION; LUNG CLEARANCE; LUNG EDEMA; LUNG FLUID; LUNG INJURY; MALE; OUTCOMES RESEARCH; OXYGENATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RESPIRATORY DISTRESS SYNDROME; SCORING SYSTEM;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; PROGNOSIS; PULMONARY EDEMA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATORY DISTRESS SYNDROME, ADULT; STATISTICS, NONPARAMETRIC;

EID: 0037251554     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200301000-00003     Document Type: Article

References (59)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
2. Bachofen A, Weibel ER: Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977; 116:589-615
3. Bachofen M, Weibel ER: Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982; 3:35-56
4. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142:1250-1257
5. Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:1376-1383
6. Matthay MA, Folkesson HG, Verkman AS: Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol 1996; 270:L487-L503
7. Lewis JF, Jobe AH: Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147:218-233
8. Gregory TJ, Longmore WJ, Moxley MA, et al: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88:1976-1981
9. Pryhuber GS, Bachurski C, Hirsch R, et al: Tumor necrosis factor-alpha decreases surfactant protein B mRNA in murine lung. Am J Physiol 1996; 270:L714-L721
10. Wispe JR, Clark JC, Warner BB, et al: Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 1990; 86:1954-1960
11. Ingenito E: Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. Am J Respir Cell Mol Biol 2001; 25:35-44
12. Ryan SF, Ghassibi Y, Liau DF: Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am J Respir Cell Mol Biol 1991; 4:33-41
13. Schochett P, Mora R, Mark L, et al: Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases. Exp Lung Res 1999; 25:595-616
14. Greene KE, Wright JR, Steinberg KP, et al: Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999; 160:1843-1850
15. Moss M, Gillespie MK, Ackerson L, et al: Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 1996; 24:1782-1786
16. Doyle RL, Szaflarski N, Modin GW, et al: Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152:1818-1824
17. Eisner MD, Thompson T, Hudson LD, et al: Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164:231-236
18. Milberg JA, Davis DR, Steinberg KP, et al: Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273:306-309
19. Abel SJ, Finney SJ, Brett SJ, et al: Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax 1998; 53:292-294
20. Bernard GR, Artigas A, Brigham KL, et al:. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
21. Verghese GM, McCormick-Shannon K, Mason RJ, et al: Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am J Respir Crit Care Med 1998; 158:386-394
22. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
23. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
24. Verghese GM, Ware LB, Matthay BA, et al: Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J Appl Physiol 1999; 87:1301-1312
25. Ware LB, Golden JA, Finkbeiner WE, et al: Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 1999; 159:980-988
26. Jayr C, Garat C, Meignan M, et al: Alveolar liquid and protein clearance in anesthetized ventilated rats. J Appl Physiol 1994; 76:2636-2642
27. Berthiaume Y, Staub NC, Matthay MA: Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 1987; 79:335-343
28. Inoue T, Matsuura E, Nagata A, et al: Enzyme-linked immunosorbent assay for human pulmonary surfactant protein D. J Immunol Methods 1994; 173:157-164
29. Takahashi H, Fujishima T, Koba H, et al: Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 2000; 162:1109-1114
30. Honda Y, Kuroki Y, Matsuura E, et al: Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995; 152:1860-1866
31. Petty TL, Reiss OK, Paul GW, et al: Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock. Am Rev Respir Dis 1977; 115:531-536
32. LeVine AM, Kurak KE, Wright JR, et al: Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 1999; 20:279-286
33. LeVine AM, Kurak KE, Bruno MD, et al: Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998; 19:700-708
34. Wright JR, Youmans DC: Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol 1993; 264:L338-L344
35. McNeely TB, Coonrod JD: Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J Infect Dis 1993; 167:91-97
36. Kabha K, Schmegner J, Keisari Y, et al: SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol 1997; 272:L344-L352
37. Botas C, Poulain F, Akiyama J, et al: Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A 1998; 95:11869-11874
38. Wert SE, Yoshida M, LeVine AM, et al: Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A 2000; 97:5972-5977
39. Korfhagen TR, Sheftelyevich V, Burhans MS, et al: Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998; 273:28438-28443
40. Greene KE, Korfhagen TR, Whitsett JA, et al: SP-D expression regulates endotoxin mediated lung inflammation in vivo. Abstr. Am J Respir Crit Care Med 2000; 161:A515
41. Wright JR: Immunomodulatory functions of surfactant. Physiol Rev 1997; 77:931-962
42. Vuk-Pavlovic Z, Standing JE, Crouch EC, et al: Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A. Am J Respir Cell Mol Biol 2001; 24:475-484
43. Hartshorn KL, White MR, Voelker DR, et al: Mechanism of binding of surfactant protein D to influenza A viruses: Importance of binding to haemagglutinin to antiviral activity. Biochem J 2000; 351:449-458
44. Kuan SF, Rust K, Crouch E: Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest 1992; 90:97-106
45. Restrepo CI, Dong Q, Savoy J, et al: Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol 1999; 21:576-585
46. Baughman RP, Sternberg RI, Hull W, et al: Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis 1993; 147:653-657
47. Gunther A, Siebert C, Schmidt R, et al: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153:176-184
48. McCormack FX, King TE Jr, Bucher BL, et al: Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 152:751-759
49. Pison U, Obertacke U, Seeger W, et al: Surfactant protein A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur J Clin Invest 1992; 22:712-718
50. Matute-Bello G, Liles WC, Steinberg KP, et al: Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999; 163:2217-2225
51. Newman V, Gonzalez RF, Matthay MA, et al: A novel alveolar type I cell-specific biochemical marker of human acute lung injury. Am J Respir Crit Care Med 2000; 161:990-995
52. Dulkerian SJ, Gonzales LW, Ning Y, et al: Regulation of surfactant protein D in human fetal lung. Am J Respir Cell Mol Biol 1996; 15:781-786
53. Kuroki Y, Takahashi H, Chiba H, et al: Surfactant proteins A and D: Disease markers. Biochim Biophys Acta 1998; 1408:334-345
54. Chida S, Phelps DS, Soll RF, et al: Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment. Pediatrics 1991; 88:84-89
55. Doyle IR, Nicholas TE, Bersten AD: Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152:307-317
56. Doyle IR, Bersten AD, Nicholas TE: Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 1997; 156:1217-1229
57. Bersten AD, Hunt T, Nicholas TE, et al: Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure. Am J Respir Crit Care Med 2001; 164:648-652
58. Crouch EC: Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998; 19:177-201
59. Zhu S, Ware LB, Geiser T, et al: Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001; 163:166-172